NCT06918002
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06918002
Title Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients (ElLen)
Acronym ElLen
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Intergroupe Francophone du Myelome
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.